59.22USD-0.49%Mkt Cap: 4.73B $P/E: 54.831d ago
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for …
Industry Peers
Diagnostics & Research$201.86BUSDP/E 29.8
$145.10BUSDP/E 39.7
$45.85BUSDP/E 44.2
$45.44BUSDP/E 42.4
$38.64BUSD
$38.44BUSDP/E 27.3
$37.13BUSDP/E 48.1
$35.13BUSDP/E 26.2
$28.78BUSDP/E 34.6
$26.98BUSDP/E 31.4
$23.18BUSDP/E 23.1
$23.12BUSDP/E 25.0
$20.55BUSD
$15.36BUSDP/E 33.9
$13.06BUSDP/E 27.3
$12.46BUSDP/E 53.7
$11.04BUSD
$9.26BUSDP/E 21.6
$5.90BUSDP/E 237.4
$5.68BUSD
$5.21BUSDP/E 44.6
$4.95BUSD
$3.75BUSDP/E 26.5
$3.54BUSD
$3.09BUSD
$2.08BUSD
$1.93BUSD
$1.83BUSD
$1.64BUSDP/E 41.7
$1.63BUSD
$1.48BUSDP/E 22.4
$1.02BUSDP/E 21.4
$898.56MUSD
$734.89MUSD
$616.40MUSDP/E 40.2
$584.63MUSD
$583.63MUSD
$293.12MUSDP/E 2.9
$292.75MUSD
$206.70MUSD
$152.09MUSD
$139.43MUSD
$97.25MUSD
$102.68MUSD
$89.37MUSDP/E 17.2
$73.19MUSD
$58.55MUSD
$42.32MUSD
$30.71MUSD
$26.61MUSD
$20.94MUSD
$16.60MUSD
$12.04MUSD
$9.95MUSD
$8.70MUSD
$8.87MUSD
$7.73MUSD
$7.43MUSD
$6.69MUSD
$6.06MUSD
$5.06MUSD
$4.47MUSD
$4.44MUSD
$2.95MUSD
$3.29MUSD
$3.18MUSD
$869.0KUSD
$314.2KUSDP/E Infinity
$19.6KUSD
Indicators:|
Key Statistics
Company
Market Cap4.73B $
Enterprise Value4.33B $
Revenue (TTM)541.74M $
Gross Profit362.53M $
Net Income (TTM)66.35M $
Revenue/Share6.861 USD
Last Price59.22 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees755
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISINUS92337F1075
Valuation
P/E (Trailing)54.83
P/E (Forward)30.99
PEG—
EV/EBITDA41.51
EV/Revenue7.98
P/S8.72
P/B3.59
EPS (TTM)1.08
EPS (Forward)1.91
52W Range
22.6196% of range60.91
52W High60.91 USD
52W Low22.61 USD
Profitability
Gross Margin70.10%
Oper. Margin16.28%
EBITDA Margin19.24%
Profit Margin12.83%
ROE5.07%
ROA4.72%
Growth
Revenue Growth21.50%
Earnings Growth288.90%
Cash Flow & Leverage
Operating CF136.31M $
CapEx (TTM)9.68M $
FCF Margin19.29%
FCF Yield2.21%
Net Debt-399.73M $
Net Debt/EBITDA-3.84
Balance Sheet
Debt/Equity0.03
Current Ratio9.30
Quick Ratio8.72
Book Value/Sh16.50 USD
Cash/Share5.503 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.7 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)56.55 USD
Upside (mean)-4.5%
Target Range45.00 USD – 70.00 USD
$45.00-4.5% to mean$70.00
# Analysts11
Ownership
Shares Out.79.79M
Float79.28M
Insiders0.54%
Institutions112.58%
Short Interest
Short Ratio4.3d
Short % Float9.96%
Short % Out.8.42%
Shares Short6.72M
Short (prev mo.)7.35M
Technical
SMA 5049.04 (+20.8%)
SMA 20040.58 (+45.9%)
Beta1.93
S&P 52W Chg20.25%
Avg Vol (30d)1.20M
Avg Vol (10d)1.00M
Technical Indicators
RSI (14)62.0
MACD2.7609
MACD Signal3.1710
MACD Hist.-0.4101
BB Upper62.69 USD
BB Middle56.89 USD
BB Lower51.08 USD
BB Width20.41%
ATR (14)2.738 USD
Vol Ratio (20d)0.65x